Related Experiment Videos
Hepatosplenic schistosomiasis: a review
G S Kibiki1, J P H Drenth, F M Nagengast
1Department of Medicine, Division of Gastroenterology and Hepatology, University Medical Centre, St Radboud Nijmegen, The Netherlands.
East African Medical Journal
|January 1, 2005
Summary
Hepatosplenic schistosomiasis (HSS) is a deadly complication of schistosomiasis, prevalent in resource-poor nations. Enhanced understanding and management strategies are crucial for improving patient outcomes and public health.
Area of Science:
- Tropical Medicine
- Infectious Diseases
- Parasitology
Background:
- Schistosomiasis is a significant global health threat, particularly in tropical and subtropical regions.
- Hepatosplenic schistosomiasis (HSS) represents the most life-threatening stage, leading to high mortality rates.
- HSS is a chronic complication resulting from the body's inflammatory response to schistosome infection.
Purpose of the Study:
- To conduct a comprehensive literature review on hepatosplenic schistosomiasis.
- To outline the current state-of-the-art management strategies for HSS.
- To share clinical experience and enhance medical knowledge on HSS management.
Main Methods:
- Literature search of the Medline database.
- Inclusion of clinical experience from gastroenterology departments.
- Selection of applicable data for resource-poor settings.
Main Results:
- Synthesized conclusions based on published studies, meta-analyses, and clinical experience.
- Established current understanding of hepatosplenic schistosomiasis.
Conclusions:
- Hepatosplenic schistosomiasis is a fatal complication predominantly affecting impoverished countries.
- Regular knowledge updates are essential for healthcare stakeholders to manage HSS effectively.
- Developing targeted management strategies is critical for addressing this public health challenge.